Clinical Trials Directory

Trials / Completed

CompletedNCT05195996

Beta Blocker Effects in Traumatic Brain Injury

Beta Blocker Effects on Patients With Traumatic Brain Injury

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Menoufia University · Academic / Other
Sex
All
Age
16 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The study will be conducted on polytrauma patient who are admitted from emergency room or postoperative with head trauma to evaluate effects of beta blocker on patients with TBI.

Detailed description

The study will be conducted on polytrauma patient who are admitted from emergency room or postoperative with head trauma . Patients will be randomly assigned into two groups by sealed envelope technique into two equal groups. Parameters assessment: * Length of ICU stay * Length of total hospital stay * CT scan to exclude another intracranial hemorrhage or increase in hemorrhage * Functional status will be assessed using the GCS * Hemodynamic data ( bl.p / hr ) * Crystalloid volume that patient need in 24h * Mortality rate

Conditions

Interventions

TypeNameDescription
DRUGPropranololintravenous propranolol for case patients
DRUGSalineintravenous saline for placebo

Timeline

Start date
2021-10-01
Primary completion
2022-03-31
Completion
2022-05-31
First posted
2022-01-19
Last updated
2023-03-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05195996. Inclusion in this directory is not an endorsement.